Pandemic Still Putting Pressure On Novartis Oncology Portfolio

CEO Concerned About Diagnosis Delays

 
• By Kevin Grogan
  
COVID-19 shadow hanging over Novartis cancer drug sales • Source: Archive

More from Anticancer

More from Therapy Areas